COPE/CE - Modern Optometry

1-16 of 35

Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment
Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment
CME/CE
Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment
Christina Y. Weng, MD, MBA, FASRS; Mark T. Dunbar, OD, FAAO
1.00 credit
Christina Y. Weng, MD, MBA, FASRS; Mark T. Dunbar, OD, FAAO
1.00 credit
Shared Care Perspectives: Retina and Optometry
Shared Care Perspectives: Retina and Optometry
CME/CE
Shared Care Perspectives: Retina and Optometry
John Kitchens, MD; Sara LeMay, OD
0.25 credits
John Kitchens, MD; Sara LeMay, OD
0.25 credits
Biomarkers and Second-Generation Treatments
Biomarkers and Second-Generation Treatments
CME/CE
Biomarkers and Second-Generation Treatments
John W. Kitchens, MD; Sara LeMay, OD
0.25 credits
John W. Kitchens, MD; Sara LeMay, OD
0.25 credits
Improving Outcomes and Coordinating Care in Diabetic Retinopathy and Diabetic Macular Edema
Improving Outcomes and Coordinating Care in Diabetic Retinopathy and Diabetic Macular Edema
CME/CE
Improving Outcomes and Coordinating Care in Diabetic Retinopathy and Diabetic Macular Edema
John Kitchens, MD; Sara LeMay, OD
0.25 credits
John Kitchens, MD; Sara LeMay, OD
0.25 credits
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
CME/CE Broadcast Replay
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
Arshad M. Khanani MD, MA, FASRS; Veeral Sheth, MD, MBA, FASRS, FACS
1.00 credit
Arshad M. Khanani MD, MA, FASRS; Veeral Sheth, MD, MBA, FASRS, FACS
1.00 credit
Overcoming Treatment Plateaus in Chronic DME
Overcoming Treatment Plateaus in Chronic DME
CME/CE
Overcoming Treatment Plateaus in Chronic DME
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
The Role of Presbyopia-Correcting Drops
The Role of Presbyopia-Correcting Drops
CME/CE
The Role of Presbyopia-Correcting Drops
Mark T. Dunbar, OD, FAAO; David Eichenbaum, MD
0.25 credits
Mark T. Dunbar, OD, FAAO; David Eichenbaum, MD
0.25 credits
Presbyopia-Correcting Drops: The Importance of Patient Selection
Presbyopia-Correcting Drops: The Importance of Patient Selection
CME/CE
Presbyopia-Correcting Drops: The Importance of Patient Selection
Christina Y. Weng, MD, MBA, FASRS; Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
0.25 credits
Christina Y. Weng, MD, MBA, FASRS; Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
0.25 credits
Retina Specialist Perspectives
Retina Specialist Perspectives
CME/CE
Retina Specialist Perspectives
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
Achieving Durable Outcomes in Treatment-Naïve nAMD
Achieving Durable Outcomes in Treatment-Naïve nAMD
CME/CE
Achieving Durable Outcomes in Treatment-Naïve nAMD
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
The Comanagement Plan: Elevating Retinal Care Through Unified Vision
The Comanagement Plan: Elevating Retinal Care Through Unified Vision
CME/CE Broadcast Replay
The Comanagement Plan: Elevating Retinal Care Through Unified Vision
Sunir J. Garg, MD, FACS, FASRS; John W. Kitchens, MD
1.00 credit
Sunir J. Garg, MD, FACS, FASRS; John W. Kitchens, MD
1.00 credit
Tracking GA Development: From Initial Symptoms to Treatment Approaches
Tracking GA Development: From Initial Symptoms to Treatment Approaches
CME/CE
Tracking GA Development: From Initial Symptoms to Treatment Approaches
Elizabeth (Beth) Richter, MD, PhD; Julie Rodman, OD, MSc
1.00 credit
Elizabeth (Beth) Richter, MD, PhD; Julie Rodman, OD, MSc
1.00 credit
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
CME/CE Broadcast Replay
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
Kathleen N. Moore, MD, MS, FASCO; Aaron Samuel Gold, OD, FAAO
1.00 credit
Kathleen N. Moore, MD, MS, FASCO; Aaron Samuel Gold, OD, FAAO
1.00 credit
Understanding Antibody-Drug Conjugates (ADCs)
Understanding Antibody-Drug Conjugates (ADCs)
CME/CE
Understanding Antibody-Drug Conjugates (ADCs)
Aaron Samuel Gold, OD, FAAO; Carlo J. Pelino, OD, FAAO
0.25 credits
Aaron Samuel Gold, OD, FAAO; Carlo J. Pelino, OD, FAAO
0.25 credits
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
CME/CE
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
Aaron Samuel Gold, OD, FAAO; Timothy G. Murray, MD, MBA, FASRS
0.25 credits
Aaron Samuel Gold, OD, FAAO; Timothy G. Murray, MD, MBA, FASRS
0.25 credits
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
CME/CE
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
Kathleen N. Moore, MD, MS, FASCO; Kamran M. Riaz, MD
0.25 credits
Kathleen N. Moore, MD, MS, FASCO; Kamran M. Riaz, MD
0.25 credits

Prev
1
2
3
Next

1/3